chr4-94575713-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006457.5(PDLIM5):c.389G>A(p.Arg130Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000039 in 1,613,708 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R130L) has been classified as Uncertain significance.
Frequency
Consequence
NM_006457.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDLIM5 | NM_006457.5 | c.389G>A | p.Arg130Gln | missense_variant | 5/13 | ENST00000317968.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PDLIM5 | ENST00000317968.9 | c.389G>A | p.Arg130Gln | missense_variant | 5/13 | 1 | NM_006457.5 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151976Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251370Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135850
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461732Hom.: 0 Cov.: 31 AF XY: 0.0000399 AC XY: 29AN XY: 727164
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151976Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74234
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2023 | The c.389G>A (p.R130Q) alteration is located in exon 5 (coding exon 4) of the PDLIM5 gene. This alteration results from a G to A substitution at nucleotide position 389, causing the arginine (R) at amino acid position 130 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at